Garlic compound, fiallyl disulfide induces cell cycle arrest in prostate cancer cell line PC-3

Molecular and Cellular Biochemistry

Volumn 288, Issue 1-2, 2006, Pages 107-113

  Arunkumar, Arumugam ^a   Vijayababu, Marati Radhakrishnan ^a   Srinivasan, Narasimman ^a   Aruldhas, Maria Michael ^a   Arunakaran, Jagedeesan ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Cell cycle arrest; Cyclin dependent kinase; Cyclins; Diallyl disulfide; Prostate cancer

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; DIALLYL DISULFIDE; GARLIC EXTRACT; PROPIDIUM IODIDE; REGULATOR PROTEIN; ALLYL COMPOUND; ANDROGEN; ANTINEOPLASTIC AGENT; CYCLIN B; DISULFIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; STAINING; WESTERN BLOTTING; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; GARLIC; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

ALLIUM SATIVUM;

ALLYL COMPOUNDS; ANDROGENS; ANTINEOPLASTIC AGENTS; CDC2 PROTEIN KINASE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN A; CYCLIN B; DISULFIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; GARLIC; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 33748202157     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9126-6     Document Type: Article

References (42)

1. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. CA Cancer J Clin 52: 23-47, 2002
2. Kish JA, Bukkapatnam R, Palazzo F: The treatment challenge of hormone-refractory prostate cancer. Cancer Control 8: 487-495, 2001
3. Brawley OW, Barnes S, Parnes H: The future of prostate cancer prevention. Ann NY Acad Sci 952: 145-152, 2001
4. Breslow N, Chan C, Dhom G, Drury R, Franks L, Gellei B, Lee Y, Lundberg S, Sparke B, Sternby N, Tulinius H: Latent carcinoma of the prostate at autopsy in seven areas. Int J Cancer 20: 680-688, 1977
5. Flanders W: Prostate cancer epidemiology. Prostate 5: 621-629, 1984
6. Haenszel W, Kurihara M: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40: 43-68, 1968
7. Severson R, Nomura A, Grove J, Stemmermann G: A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49: 1857-1860, 1989
8. Adlercreutz H: Western diet aSd Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 50 (Suppl.): 3-23, 1990
9. Hsing AW, Chokkalingam AP, Gao YT, Madigan MP, Deng J, Gridley G, Fraumeni Jr JF: Allium vegetables and risA of prostate cancer: a population-based study, J Natl Cancer Inst 94: 1648-1651, 2002
10. Milner JA: Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Adv Exp Med Biol 492: 69-81, 2001
11. Siegel G, Malmsten M, Pietzsch J, Schmidt A, Buddecke E, Michel F, Ploch M, Schneider W: The effect of garlic on arteriosclerotic nanoplaque formation and size. Int J Phytotherapy Phytopharmacol 11: 24-35, 2004
12. Tsao S, Yin M: In vitro activity of garlic oil and four diallyl sulphides against antibiotic-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae. J Antimicrobial Chemotherapy 47: 665-670, 2001
13. Kwon MJ, Song YS, Choi MS, Park SJ, Jeong KS, Song YO: Cholesteryl ester transfer protein activity and atherogenic parameters in rabbits supplemented with cholesterol and garlic powder. Life Sci 72: 2953-2964, 2003
14. Hong YS, Ham YA, Choi JH, Kim J: Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2. Bax, and p53 in non small cell lung cancer cell lines. Exp Mol Med 32: 127-134, 2000
15. Nakagawa H, Tsuta K, Kiuchi K, Senzaki H, Tanaka K, Hioki A, Tsubura A: Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis 22: 891-897, 2001
16. Takezaki T, Gao CM, Wu JZ, Ding JH, Liu YT, Zhang Y, Li SP, Su P, Liu TK, Tajima K: Dietary protective and risk factors for esophageal and stomach cancers in a low-epidemic area for stomach cancer in Jiangsu Province. China: Comparison with those in a high-epidemic area. Jap J Cancer Res 92: 1157-1165, 2001
17. Iimuro M, Shibata H, Kawamori T, Matsumoto T, Arakawa T, Sugimura T, Wakabayashi K: Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett 187: 61-68, 2002
18. Ku DD, Abdel-Razek TT, Dai J, Kim-Park S, Fallon MB, Abrams GA: Garlic and its active metabolite allicin produce endothelium- and nitric oxide-dependent relaxation in rat pulmonary arteries. Clin Exp Pharmacol Physiol 29: 84-91, 2002
19. Guyonnet D, Belloir C, Suschetet M, Siess MH, Le Bon AM: Liver subcellular fractions from rats treated by organosulfur compounds from Allium modulate mutagen activation. Mutat Res 466: 17-26, 2000
20. Le Bon AM, Roy C, Dupont C, Suschetet M: In vivo antigenotoxic effects of dietary allyl sulfides in the rat. Cancer Lett 114: 131-134, 1997
21. Sheen LY, Wu CC, Lii CK, Tsai SJ: Effect of diallyl sulfide and diallyl disulfide, the active principles of garlic, on the aflatoxin B-1-induced DNA damage in primary rat hepatocytes. Toxicol. Lett 122: 45-52, 2001
22. Guyonnet D, Belloir C, Suschetet M, Siess MH, Le Bon AM: Antimutagenic activity of organosulfur compounds from Allium is associated with phase II enzyme induction. Mutat Res 495: 135-145, 2001
23. Siess MH, Le Bon AM, Canivenc-Lavier MC, Suschetet M: Modification of hepatic drug-metabolizing enzymes in rats treated with alkyl sulfides. Cancer Lett 120: 195-201, 1997
24. Hu X, Singh SV: Glutathione S-transferases of female A/J mouse lung and their induction by anticarcinogenic organosulfides from garlic. Arch Biochem Biophys 340: 279-286, 1997
25. Guyonnet D, Siess MH, Le Bon AM, Suschetet M: Modulation of phase II enzymes by organosulfur compounds from allium vegetables in rat tissues. Toxicol Appl Pharmacol 154: 50-58, 1999
26. Knowles LM, Milner JA: Allyl sulfides modify cell growth. Drug Metabol Drug Interact 17: 81-107, 2000
27. Sundaram SG, Milner JA: Diallyl disulfide suppresses the growth of human colon tumor cell xenografts in athymic nude mice. J Nutr 126: 1355-1361, 1996
28. Arunkumar A, Vijayababu MR, Kanagaraj P, Balasubramanian K, Aruldhas MM, Arunakaran J: Growth suppressing effect of garlic compound diallyl disulfide on prostate cancer cell line (PC-3) in vitro. Biol Pharm Bull 28: 740-743, 2005
29. Gunadharini DN, Arunkumar A, Krishnamoorthy G, Muthuvel R, Vijayababu MR, Kanagaraj P, Srinivasan N, Aruldhas MM, Arunakaran J: Antiproliferative effect of diallyl disulfide (DADS)on prostatic cancer cell line (LNCaP). Cell Biochem Func 23: 1-6, 2005
30. Yuan JP, Ling H, Zhang MX, Liu Y, Song Y, Su Q: Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways, Ai Zheng 23: 169-172, 2004
31. Rasola A, Geuna M: A flowcytometry assay simultaneously detects independent apoptotic parameters. Cytometry 45: 151-157, 2001
32. Lawson LD, Wang ZJ: Pre-hepatic fate of the organosulfur compounds derived from garlic [Allium sativum]. Planta Med 59: A688-689, 1993
33. Dausch JG, Nixon DW: Garlic: A review of its relationship to malignant disease. Prev Med 19: 346-61, 1990
34. Druesne N, Pagniez A, Mayeur C, Thomas M, Cherbuy C, Duee PH, Martel P, Chaumontet C: Diallyl disulfide (DADS)increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines. Carcinogenesis 25: 1227-1236, 2004
35. Yuan JP, Ling H, Zhang MX, Liu Y, Song Y, Su Q: Diallyl disulfide induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways, Ai Zheng 23: 169-172, 2004
36. Knowles LM, Milner JA: Depressed p34cdc2 kinase activity and G2/M phase arrest induced by diallyl disulfide in HCT-15 cells, Nutr Cancer 30: 169-174, 1998
37. Wu CC, Chung JG, Tsai SJ, Yang JH, Sheen LY: Differential effects of allyl sulfides from garlic essential oil on cell cycle regulation in human liver tumor cells. Food Chemical Toxicol 42: 1937-1947, 2004
38. King RW, Jackson PK, Kirschner MW: Mitosis in transition. Cell 79: 563-571, 1994
39. Coleman TR, Dunphy WG: Cdc2 regulatory factors. Curr Opin Cell Biol 6: 877-882, 1994
40. Obaya AJ, Sedivy JM: Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci 59: 126-142, 2002
41. Bulavin DV, Higashimoto Y, Popoff I, Gaarde W, Basrur V, Potapova O, Appella E, Fornace A: Initiation of a G2/M checkpoint after ultraviolet radiation require p38 kinase. Nature 411: 102-106, 2001
42. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. Mitotic and G2 checkpoint control: Regulation of 14-3-3-protein binding by phosphorylation of cdc25C on serine- 216. Science 277: 1501-1505, 1997